Loading live market data…

Krystal Biotech, Inc.

NASDAQ:KRYS

$342.2542 USD

$2.82 (0.83%)

Volume
111.85K
Average Volume
315.3K
Market Capitalization
$10.09B
P/E Ratio
44.16
Dividend Yield
0.00%
Price Target
$327.00
Year High
$382.54
Year Low
$130.50
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.46

KRYS Estimated and Actual Revenue by Quarter

KRYS Estimated and Actual EPS by Quarter

KRYS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 78.42M 85.52M 81.24M 76.75M 83.7M 79.52M
2027-09-30 2 67.28M 73.37M 69.7M 65.85M 71.81M 68.22M
2027-06-30 2 59.53M 64.92M 61.67M 58.27M 63.54M 60.36M
2027-03-31 3 53.3M 58.12M 55.21M 52.16M 56.89M 54.04M
2026-12-31 3 52.77M 57.55M 54.67M 51.65M 56.33M 53.51M
2026-09-30 4 48.72M 53.13M 50.47M 47.68M 52M 49.4M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 106.32M 118.97M 111.35M 196.22M 213.98M 203.28M
2027-09-30 2 86.22M 96.48M 90.3M 168.34M 183.58M 174.4M
2027-06-30 2 72.53M 81.16M 75.96M 148.96M 162.44M 154.32M
2027-03-31 3 79.23M 88.66M 82.98M 133.36M 145.43M 138.16M
2026-12-31 3 62.97M 70.46M 65.95M 132.04M 143.99M 136.8M
2026-09-30 4 51.91M 65.04M 60.27M 121.9M 132.94M 126.29M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 208.33M 227.19M 215.83M 1 3.48514 3.89971 3.65
2027-09-30 2 178.73M 194.91M 185.17M 1 2.82631 3.1625 2.96
2027-06-30 2 158.15M 172.47M 163.84M 1 2.37753 2.66035 2.49
2027-03-31 3 141.59M 154.4M 146.69M 1 2.59715 2.90608 2.72
2026-12-31 3 140.19M 152.88M 145.24M 1 2.06418 2.30972 2.16182
2026-09-30 4 129.43M 141.14M 134.08M 5 1.70163 2.13193 1.97546